CAMARUS thoughtsSo looking at Camarus there are some mixed signals currently, so it's best to wait and see how things will pan out.
We can however already look at some different scenarios to prepare ourselves.
Green scenario:
CAMARUS broke above resistance, retested this resistance and turned it into support. Whil
Next report date
Report period
Q1 2024
EPS estimate
0.96SEK
Revenue estimate
410.92 MSEK
7.8SEK
431.44 MSEK
1.72 BSEK
31.20 M
About CAMURUS AB
Sector
CEO
Sven Fredrik Tiberg
Headquarters
Lund
Website
Employees (FY)
213
Founded
2004
ISIN
SE0007692850
FIGI
BBG00JHW74G6
Camurus AB operates as a research based pharmaceutical company. The firm engages in the research, development and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0RD1 is 476.4 SEK — it has decreased by 0.04% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CAMURUS AB NPV stocks are traded under the ticker 0RD1.
CAMURUS AB NPV is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
0RD1 stock is 2.85% volatile and has beta coefficient of 0.53. Check out the list of the most volatile stocks — is CAMURUS AB NPV there?
0RD1 earnings for the last quarter are 1.50 SEK per share, whereas the estimation was 0.71 SEK resulting in a 112.06% surprise. The estimated earnings for the next quarter are −1.75 SEK per share. See more details about CAMURUS AB NPV earnings.
CAMURUS AB NPV revenue for the last quarter amounts to 383.99 M SEK despite the estimated figure of 326.86 M SEK. In the next quarter revenue is expected to reach 375.08 M SEK.
Yes, you can track CAMURUS AB NPV financials in yearly and quarterly reports right on TradingView.
0RD1 stock has risen by 1.40% compared to the previous week, the month change is a 9.52% fall, over the last year CAMURUS AB NPV has showed a 107.31% increase.
0RD1 net income for the last quarter is −15.21 M SEK, while the quarter before that showed 86.40 M SEK of net income which accounts for −117.60% change. Track more CAMURUS AB NPV financial stats to get the full picture.
Today CAMURUS AB NPV has the market capitalization of 28.24 B, it has decreased by 3.38% over the last week.
No, 0RD1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0RD1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CAMURUS AB NPV stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 29, 2024, the company has 213.00 employees. See our rating of the largest employees — is CAMURUS AB NPV on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CAMURUS AB NPV technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CAMURUS AB NPV stock shows the buy signal. See more of CAMURUS AB NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CAMURUS AB NPV future price: according to them, 0RD1 price has a max estimate of 690.00 SEK and a min estimate of 445.00 SEK. Read a more detailed CAMURUS AB NPV forecast: see what analysts think of CAMURUS AB NPV and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CAMURUS AB NPV EBITDA is 546.34 M SEK, and current EBITDA margin is 31.70%. See more stats in CAMURUS AB NPV financial statements.